Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral Therapy
DOI: https://doi.org/10.2147/ijgm.s462844
IF: 2.145
2024-06-07
International Journal of General Medicine
Abstract:Hang Wang, 1, &ast Bobin Hu, 1, &ast Hengkai Liang, 1 Rongming Wang, 1 Lu Wei, 1 Tumei Su, 1 Qingmei Li, 1 Qianbing Yin, 1 Yanfei Feng, 1 Minghua Su, 1 Jianning Jiang 1, 2 1 Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China; 2 Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor(Guangxi Medical University), Ministry of Education, Nanning, Guangxi, 530021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianning Jiang; Minghua Su, Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, People's Republic of China, Tel +86-0771-5356531, Email ; Purpose: Few studies have reported the integrated characteristics of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after long-term antiviral therapy. This study aimed to investigate the HBV integration features in HBV-HCC patients who had undergone long-term antiviral therapy, evaluate their impact on clinical indicators, and analyze the potential mechanisms involved. Patients and Methods: We utilized genome-wide association study (GWAS) to analyze liver cancer tissues and detect the presence of HBV integration. Seventeen patients with HBV integration were included in the integration (Int) group, while the remaining five patients were included in the non-integration (N-int) group. Clinical indicators were regularly monitored and compared between the two groups. The characteristics of HBV integration patterns were analyzed, and differences between the groups were explored at the chromosome and genomic levels. Results: After long-term antiviral therapy, although the frequency of HBV integration in HBV-HCC was reduced, residual HBV integration still accelerated the development of HCC. It affected the diagnosis, treatment, and prognosis of patients. HBV integration events led to changes in chromosome structure, which were closely related to HCC. Novel fusion genes were detected at a high frequency and had the potential to be specific detection sites for HBV-HCC. Conclusion: HBV integration events are synergistically involved in the human genome and HBV, which can lead to chromosome structural instability, gene rearrangement events closely related to HCC production, and the formation of new specific fusion genes. Keywords: hepatitis B virus, long-term antiviral therapy, hepatocellular carcinoma, integration, gene rearrangement Primary liver cancer (PLC) is the third most common cause of cancer-related deaths worldwide. 1,2 The predominant histological type of PLC is hepatocellular carcinoma (HCC). 3 Factors contributing to HCC occurrence include hepatitis virus infection, long-term excessive alcohol consumption, and chronic exposure to aflatoxin. Notably, hepatitis B virus (HBV) infection is a significant factor leading to HCC, 4–6 particularly in China, where approximately 80% of HCC cases are associated with HBV infection. 7,8 Despite the widespread use of nucleos(t)ide analogues (NUCs) for anti-HBV therapy, the incidence of HBV-related HCC has declined. However, HBV-HCC still occurs in some patients, with HBV integration playing a crucial role in this process. 9 Increasing research has focused on HBV integration events, revealing that integration of HBV genes with host genes is not a random occurrence; 10,11 rather, HBV gene fragments have a propensity to integrate into functional regions of the host genome, such as promoter regions and Cytosine-phosphate-Guanine (CpG) islands, thereby affecting host gene regulation and expression. 12,13 Research indicates that HBV integration can occur early after the host is infected and is detectable at all stages of chronic infection. 14 The frequent detection of HBV-host integration events suggest that this virus has an evolutionary advantage, 15 leading to biological effects throughout prolonged infection. For example, HBV S gene integration segments found early in infection can have long-term impacts on the host, independently producing surface antigens. 16 Even after antiviral treatment, these segments still contribute to the development of liver cancer. 13 Despite extensive research on HBV integration, its exact mechanisms remain unknown. Additionally, most studies are cross-sectional and only investigate integration characteristics at the time of HBV-HCC occurrence, neglecting long-term factors -Abstract Truncated-
medicine, general & internal